Robert Rudolph was recently quoted in Massachusetts Lawyers Weekly for his analysis of a federal court decision enforcing a noncompete against a former medical products executive.

In Fresenius USA Manufacturing, Inc. v. Much, a federal court granted Fresenius a preliminary injunction restricting its former executive from working for a direct competitor through July 24, 2027. The court found that the executive’s noncompete agreements complied with the Massachusetts Noncompetition Agreement Act (MNAA), including its requirements regarding the scope of the restrictions.

Robert described the decision as a “road map” for how a well-drafted noncompete can satisfy the MNAA. “It’s one of the clearer post-Noncompete Act decisions that confirms employers can still obtain preliminary injunctive relief against a senior departing executive,” Robert said.

Robert agreed with the court’s conclusion that the noncompete agreements were not broader than necessary to protect the employer’s legitimate business interests. “That the court’s decision was tied to the employee’s actual duties rather than a blanket restriction across the whole enterprise tracks the general approach of courts requiring duty-based and not entity-based analysis, which the facts in the record satisfied,” he said.

Read the article “Medtech company’s noncompetes enforceable under MNAA” on the Massachusetts Lawyers Weekly website (subscription required).